List of Tables
Table 1. Global Vector-Based RNAi Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Vector-Based RNAi Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Vector-Based RNAi Market Competitive Situation by Manufacturers in 2024
Table 4. Global Vector-Based RNAi Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Vector-Based RNAi Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Vector-Based RNAi Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Vector-Based RNAi Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Vector-Based RNAi Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Vector-Based RNAi, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Vector-Based RNAi, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Vector-Based RNAi, Product Type & Application
Table 12. Global Key Manufacturers of Vector-Based RNAi, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Vector-Based RNAi by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vector-Based RNAi as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Vector-Based RNAi Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Vector-Based RNAi Sales by Region (2020-2025) & (K Units)
Table 18. Global Vector-Based RNAi Sales Market Share by Region (2020-2025)
Table 19. Global Vector-Based RNAi Sales by Region (2026-2031) & (K Units)
Table 20. Global Vector-Based RNAi Sales Market Share by Region (2026-2031)
Table 21. Global Vector-Based RNAi Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Vector-Based RNAi Revenue Market Share by Region (2020-2025)
Table 23. Global Vector-Based RNAi Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Vector-Based RNAi Revenue Market Share by Region (2026-2031)
Table 25. North America Vector-Based RNAi Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Vector-Based RNAi Sales by Country (2020-2025) & (K Units)
Table 27. North America Vector-Based RNAi Sales by Country (2026-2031) & (K Units)
Table 28. North America Vector-Based RNAi Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Vector-Based RNAi Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Vector-Based RNAi Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Vector-Based RNAi Sales by Country (2020-2025) & (K Units)
Table 32. Europe Vector-Based RNAi Sales by Country (2026-2031) & (K Units)
Table 33. Europe Vector-Based RNAi Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Vector-Based RNAi Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Vector-Based RNAi Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Vector-Based RNAi Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Vector-Based RNAi Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Vector-Based RNAi Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Vector-Based RNAi Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Vector-Based RNAi Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Vector-Based RNAi Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Vector-Based RNAi Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Vector-Based RNAi Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Vector-Based RNAi Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Vector-Based RNAi Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Vector-Based RNAi Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Vector-Based RNAi Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Vector-Based RNAi Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Vector-Based RNAi Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Vector-Based RNAi Sales (K Units) by Type (2020-2025)
Table 51. Global Vector-Based RNAi Sales (K Units) by Type (2026-2031)
Table 52. Global Vector-Based RNAi Sales Market Share by Type (2020-2025)
Table 53. Global Vector-Based RNAi Sales Market Share by Type (2026-2031)
Table 54. Global Vector-Based RNAi Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Vector-Based RNAi Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Vector-Based RNAi Revenue Market Share by Type (2020-2025)
Table 57. Global Vector-Based RNAi Revenue Market Share by Type (2026-2031)
Table 58. Global Vector-Based RNAi Price (US$/Unit) by Type (2020-2025)
Table 59. Global Vector-Based RNAi Price (US$/Unit) by Type (2026-2031)
Table 60. Global Vector-Based RNAi Sales (K Units) by Application (2020-2025)
Table 61. Global Vector-Based RNAi Sales (K Units) by Application (2026-2031)
Table 62. Global Vector-Based RNAi Sales Market Share by Application (2020-2025)
Table 63. Global Vector-Based RNAi Sales Market Share by Application (2026-2031)
Table 64. Global Vector-Based RNAi Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Vector-Based RNAi Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Vector-Based RNAi Revenue Market Share by Application (2020-2025)
Table 67. Global Vector-Based RNAi Revenue Market Share by Application (2026-2031)
Table 68. Global Vector-Based RNAi Price (US$/Unit) by Application (2020-2025)
Table 69. Global Vector-Based RNAi Price (US$/Unit) by Application (2026-2031)
Table 70. Merck & Co. Company Information
Table 71. Merck & Co. Description and Business Overview
Table 72. Merck & Co. Vector-Based RNAi Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Merck & Co. Vector-Based RNAi Product
Table 74. Merck & Co. Recent Developments/Updates
Table 75. Phio Pharmaceutical Company Information
Table 76. Phio Pharmaceutical Description and Business Overview
Table 77. Phio Pharmaceutical Vector-Based RNAi Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Phio Pharmaceutical Vector-Based RNAi Product
Table 79. Phio Pharmaceutical Recent Developments/Updates
Table 80. Quark Pharmaceuticals Company Information
Table 81. Quark Pharmaceuticals Description and Business Overview
Table 82. Quark Pharmaceuticals Vector-Based RNAi Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Quark Pharmaceuticals Vector-Based RNAi Product
Table 84. Quark Pharmaceuticals Recent Developments/Updates
Table 85. Thermo Fisher Scientific Company Information
Table 86. Thermo Fisher Scientific Description and Business Overview
Table 87. Thermo Fisher Scientific Vector-Based RNAi Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Thermo Fisher Scientific Vector-Based RNAi Product
Table 89. Thermo Fisher Scientific Recent Developments/Updates
Table 90. Silence Therapeutics Company Information
Table 91. Silence Therapeutics Description and Business Overview
Table 92. Silence Therapeutics Vector-Based RNAi Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Silence Therapeutics Vector-Based RNAi Product
Table 94. Silence Therapeutics Recent Developments/Updates
Table 95. Qiagen NV Company Information
Table 96. Qiagen NV Description and Business Overview
Table 97. Qiagen NV Vector-Based RNAi Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Qiagen NV Vector-Based RNAi Product
Table 99. Qiagen NV Recent Developments/Updates
Table 100. Ionis Pharmaceutical Company Information
Table 101. Ionis Pharmaceutical Description and Business Overview
Table 102. Ionis Pharmaceutical Vector-Based RNAi Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Ionis Pharmaceutical Vector-Based RNAi Product
Table 104. Ionis Pharmaceutical Recent Developments/Updates
Table 105. Dicerna Pharmaceuticals Company Information
Table 106. Dicerna Pharmaceuticals Description and Business Overview
Table 107. Dicerna Pharmaceuticals Vector-Based RNAi Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Dicerna Pharmaceuticals Vector-Based RNAi Product
Table 109. Dicerna Pharmaceuticals Recent Developments/Updates
Table 110. Arrowhead Pharmaceuticals Company Information
Table 111. Arrowhead Pharmaceuticals Description and Business Overview
Table 112. Arrowhead Pharmaceuticals Vector-Based RNAi Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Arrowhead Pharmaceuticals Vector-Based RNAi Product
Table 114. Arrowhead Pharmaceuticals Recent Developments/Updates
Table 115. Arcturus Therapeutics Company Information
Table 116. Arcturus Therapeutics Description and Business Overview
Table 117. Arcturus Therapeutics Vector-Based RNAi Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Arcturus Therapeutics Vector-Based RNAi Product
Table 119. Arcturus Therapeutics Recent Developments/Updates
Table 120. Alnylam Pharmaceuticals Company Information
Table 121. Alnylam Pharmaceuticals Description and Business Overview
Table 122. Alnylam Pharmaceuticals Vector-Based RNAi Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Alnylam Pharmaceuticals Vector-Based RNAi Product
Table 124. Alnylam Pharmaceuticals Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Vector-Based RNAi Distributors List
Table 128. Vector-Based RNAi Customers List
Table 129. Vector-Based RNAi Market Trends
Table 130. Vector-Based RNAi Market Drivers
Table 131. Vector-Based RNAi Market Challenges
Table 132. Vector-Based RNAi Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
Table 136. Authors List of This Report
List of Figures
Figure 1. Product Picture of Vector-Based RNAi
Figure 2. Global Vector-Based RNAi Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Vector-Based RNAi Market Share by Type: 2024 & 2031
Figure 4. siRNA Design Product Picture
Figure 5. siRNA Vectors Product Picture
Figure 6. Custom siRNA Construction Product Picture
Figure 7. Global Vector-Based RNAi Market Value by Application (2020-2031) & (US$ Million)
Figure 8. Global Vector-Based RNAi Market Share by Application: 2024 & 2031
Figure 9. Hospitals
Figure 10. Speciality Clinics
Figure 11. Global Vector-Based RNAi Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Vector-Based RNAi Market Size (2020-2031) & (US$ Million)
Figure 13. Global Vector-Based RNAi Sales (2020-2031) & (K Units)
Figure 14. Global Vector-Based RNAi Average Price (US$/Unit) & (2020-2031)
Figure 15. Vector-Based RNAi Report Years Considered
Figure 16. Vector-Based RNAi Sales Share by Manufacturers in 2024
Figure 17. Global Vector-Based RNAi Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Vector-Based RNAi Players: Market Share by Revenue in Vector-Based RNAi in 2024
Figure 19. Vector-Based RNAi Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Vector-Based RNAi Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Vector-Based RNAi Sales Market Share by Country (2020-2031)
Figure 22. North America Vector-Based RNAi Revenue Market Share by Country (2020-2031)
Figure 23. United States Vector-Based RNAi Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Vector-Based RNAi Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Vector-Based RNAi Sales Market Share by Country (2020-2031)
Figure 26. Europe Vector-Based RNAi Revenue Market Share by Country (2020-2031)
Figure 27. Germany Vector-Based RNAi Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Vector-Based RNAi Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Vector-Based RNAi Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Vector-Based RNAi Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Vector-Based RNAi Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Vector-Based RNAi Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Vector-Based RNAi Revenue Market Share by Region (2020-2031)
Figure 34. China Vector-Based RNAi Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Vector-Based RNAi Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Vector-Based RNAi Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Vector-Based RNAi Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Vector-Based RNAi Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Vector-Based RNAi Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Indonesia Vector-Based RNAi Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Thailand Vector-Based RNAi Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Malaysia Vector-Based RNAi Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America Vector-Based RNAi Sales Market Share by Country (2020-2031)
Figure 44. Latin America Vector-Based RNAi Revenue Market Share by Country (2020-2031)
Figure 45. Mexico Vector-Based RNAi Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil Vector-Based RNAi Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina Vector-Based RNAi Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Middle East and Africa Vector-Based RNAi Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Vector-Based RNAi Revenue Market Share by Country (2020-2031)
Figure 50. Turkey Vector-Based RNAi Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Vector-Based RNAi Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. UAE Vector-Based RNAi Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Global Sales Market Share of Vector-Based RNAi by Type (2020-2031)
Figure 54. Global Revenue Market Share of Vector-Based RNAi by Type (2020-2031)
Figure 55. Global Vector-Based RNAi Price (US$/Unit) by Type (2020-2031)
Figure 56. Global Sales Market Share of Vector-Based RNAi by Application (2020-2031)
Figure 57. Global Revenue Market Share of Vector-Based RNAi by Application (2020-2031)
Figure 58. Global Vector-Based RNAi Price (US$/Unit) by Application (2020-2031)
Figure 59. Vector-Based RNAi Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
